Diverse Clinical and Molecular Characteristics of Advanced POLE-Mutated Endometrial Carcinoma: Emphasis on Aggressive Variants and Co-Occurring Mutations - Quiz - MDSpire

Diverse Clinical and Molecular Characteristics of Advanced POLE-Mutated Endometrial Carcinoma: Emphasis on Aggressive Variants and Co-Occurring Mutations

  • By

  • Nicolo Cavasin

  • Sami Kilzie

  • Mattia Vinci

  • Rita Trozzi

  • Camilla Nero

  • Stefano Restaino

  • Chiara Cassani

  • Sandro Pignata

  • Carmela Pisano

  • Giuseppe Scibilia

  • Robert Fruscio

  • Rosanna Mancari

  • Adolfo Favaretto

  • Matteo Fassan

  • Luisa Toffolatti

  • Giovanna Gallina

  • Francesco Fanfani

  • Vanda Salutari

  • Grazia Artioli

  • April 29, 2026

  • 0 min

Share

Original Source(s)

Diverse Clinical and Molecular Characteristics of Advanced POLE-Mutated Endometrial Carcinoma: Emphasis on Aggressive Variants and Co-Occurring Mutations

  • by Nicolo Cavasin, Sami Kilzie, Mattia Vinci, Rita Trozzi, Camilla Nero, Stefano Restaino, Chiara Cassani, Sandro Pignata, Carmela Pisano, Giuseppe Scibilia, Robert Fruscio, Rosanna Mancari, Adolfo Favaretto, Matteo Fassan, Luisa Toffolatti, Giovanna Gallina, Francesco Fanfani, Vanda Salutari, Grazia Artioli

  • April 29, 2026

Related Content

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy